HISTORICAL FACTS: 2 | History Defined

Busy day in London for KTR, team

Busy day in London for KTR, team 

The Hindu · May 13, 2023

AstraZeneca overtakes Pfizer as crunch week for UK pharma looms

Driven by a revamped drug portfolio, AstraZeneca is expected to report revenues of $10.7bn in its latest quarterly results

The Guardian - UK · Apr 24, 2023

Moonpig flotation price, like so many, was always pie-in-the-sky thinking

You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses

The Guardian - UK · Dec 7, 2022

I tested an AI app for visually impaired people – and this is what I found

The Microsoft Seeing AI app aims to assist people who are visually impaired with buying health products. Elin Williams, 24, author of the disability and lifestyle blog My Blurred World, gives it a go – and reveals her verdict

The Guardian - UK · Nov 3, 2022

The only party not getting heartburn over GSK demerger is the lawyers

The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years

The Guardian - UK · Sep 20, 2022

Sensodyne maker Haleon sees 22% profit rise in first results since GSK demerger

Haleon demerged from its parent company in July

Evening Standard · Sep 20, 2022

Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke

Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar

Benzinga · Aug 11, 2022

Haleon’s debut suggests it may not be the jewel in GSK’s medicine cabinet

Consumer goods spin-off makes few waves in biggest European listing for more than a decade

The Guardian - UK · Jul 18, 2022

Benzinga Before The Bell: Amazon Wages Price War On Tesco, Biden's Campaign Promise To Free Cannabis Prisoners, H&M Exits Russia And Other Top Financial Stories Monday, July 18

Reuters GSK Completes Spin-Off Of Its Consumer Healthcare Business

Benzinga · Jul 18, 2022

Haleon provides temporary relief from London listings drought

Advisory fee bonanza will put bread on the tables of City corporate finance professionals

Evening Standard · Jul 18, 2022